Propiverine Hydrochloride Extended-Release Capsule for Overactive Bladder
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this Phase III study is to evaluate the efficacy and safety of Propiverine
Hydrochloride Extended-Release Capsule in the treatment of overactive bladder in Chinese
population with urgent micturition, frequent micturition and/or urge urinary incontinence.